MSB 3.33% $1.40 mesoblast limited

Cell Therapy News/Articles, page-5966

  1. 132 Posts.
    lightbulb Created with Sketch. 67
    Hi @Domesicgod,

    I'm so happy to hold all 3 of these Aussie Bio-tech stocks!

    CSL is well and truly an great Australian icon. I staunchly believe MSB is going to be great; and as for SPL , I sincerely hope management won't waste our Australian innovative technologies and will execise its businesss accumen to reach the full potential of the company.

    At times, I had complained Msb's management kept small investors in the dark and didn't care much about small potatoes like us.
    But Msb has changed my impressions since mid last year and now I felt blesssed to have Msb' board, SI and his executive team to lead the company!

    I've gradually increase weightings of MSB at the expense of SPL and CSL, and now MSB makes up 80% of my portfolio , while SPL at 7.6% and CSL 5.5%. (It was very different 5 years ago, with CSL making up just less than half of my portfolio then , and MSB/SPL combined at around 15% )

    Just wonder what the weightimgs of these 3 stocks are in your portfolio @Domesicgod?

    Cheers!
    SOM
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.